• HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your event to ACNR
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR funded?
    • Editorial Board
    • Peer Reviewers
    • Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Mail Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • From the Editor
    • Articles
      • View All
      • Peer Reviewed
      • Personal Perspectives
      • History
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Journal Signup
    • ACNR Privacy Policy
  • Menu

Neurokinex funding facilitates bursaries to support children with paralysis

Posted on 15 May, 2019 - Industry News

New bursaries available

Eisai and UK Dementia Research Institute jointly launch new programme to accelerate dementia research

Posted on 14 May, 2019 - Industry News

News from Eisai and the UK Dementia Research Institute

Neurology Formative Test Questions – deadline 26th May

Posted on 9 May, 2019 - Industry News, Neurology News

News from ebrain

New Rehabilitation Prescription – RP2019 now available  

Posted on 14 March, 2019 - Industry News, Rehabilitation Articles

New Rehabilitation Prescription now available

Australian medicinal cannabis company Althea to launch in UK

Posted on 13 February, 2019 - Industry News

News from Althea

ACNR announces new partnership with Taylor & Francis

Posted on 4 February, 2019 - Book Reviews, Industry News

20% book discount offer from Taylor & Francis

Christchurch Group announces appointment of Donald Muir as Non-Executive Chairman

Posted on 18 January, 2019 - Industry News

News from The Christchurch Group

NHS England will fund everolimus for TSC-related refractory epilepsy

Posted on 3 January, 2019 - Industry News, Neurology News, Online First

News from the Tuberous Sclerosis Association

Viewpoints: News from the ILAE British Chapter Annual Scientific Meeting

Posted on 14 December, 2018 - Online First, Sponsored Feature

Download our 8 page newsletter, produced in association with LivaNova

  • «
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 49
  • »

Recent News

  •  A blood test for early cognitive decline?
  • Tavapadon: A game-changing partial dopamine agonist?
  • New mechanism for blood flow regulation in the brain
  • Sleep apnoea linked to changes in the brain
  • Genetic testing for neurodevelopmental conditions
  • ‘Digital twin’ brain tech for people with Parkinson’s given funding
  • Accelerated Approval in Huntington’s disease?
  • Vamorolone for Duchenne Muscular Dystrophy
  • Episodic migraine in children and adolescents
  • A link between gut bacteria and Alzheimer’s disease?

Categories

  • ACNR News (8)
  • Acquired Brain Injury (14)
  • Alzheimer's Disease (27)
  • Amyotrophic Lateral Sclerosis (ALS) (7)
  • Artificial Intelligence (6)
  • Association of British Neurologists Trainees (4)
  • Australia/New Zealand (1)
  • Awards & Appointments (10)
  • Book Reviews (2)
  • Brain Mapping (2)
  • Brain tumours (3)
  • Case Reports (15)
  • Charcot-Marie-Tooth Disease (1)
  • Charity (5)
  • Cognition (3)
  • Comment (2)
  • Course & Conference Previews (11)
  • Courses & Conferences (1)
  • COVID-19 Articles (4)
  • Dementia (12)
  • Digital Health (2)
  • Epilepsy (16)
  • Essay (1)
  • Genetics (1)
  • Headache (17)
  • Hereditary Spastic Paraplegia (1)
  • Huntington's disease (4)
  • Industry News (178)
  • Journal Reviews (1)
  • Major Depressive Disorder (3)
  • Management Topics in Epilepsy (1)
  • Movement Disorders (14)
  • Multiple Sclerosis (27)
  • Myasthenia Gravis (7)
  • Neurodegenerative diseases (1)
  • Neurodevelopmental disorders (4)
  • Neuroimmunology (2)
  • Neurological Literature (2)
  • Neurology News (37)
  • Neuromuscular (1)
  • Neuropsychiatry (2)
  • Neurosurgery (1)
  • NHS News (2)
  • Online First (14)
  • Pain (4)
  • Parkinson’s Disease (28)
  • Rehabilitation (10)
  • Rehabilitation Articles (4)
  • Research (6)
  • Sleep (3)
  • Sleep Series (4)
  • Special Feature (6)
  • Sponsored Feature (7)
  • Stroke (10)
  • Stroke Series (3)
  • Syncope (1)
  • Uncategorised (45)
  • Uncategorized (1)
  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • X
  • Linkedin

RSS FEEDS

  • ACNR RSS
  • All
  • Articles
  • Events

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events. For UK-based specialists join our journal mailing list.

© 2024 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue